Agency
National Institute of Health (NIH)
Institute
National Library of Medicine (NLM)
Type
Continuing Education Training Grants (T15)
Project #
5T15LM007044-02
Application #
3528956
Study Section
(SRC)
Project Start
1984-07-01
Project End
1989-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
Birkmeyer, J D; O'Connor, G T; Quinton, H B et al. (1995) The effect of peripheral vascular disease on in-hospital mortality rates with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. J Vasc Surg 21:445-52
Disch, D L; Greenberg, M L; Holzberger, P T et al. (1994) Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Ann Intern Med 120:449-57
Birkmeyer, J D; AuBuchon, J P; Littenberg, B et al. (1994) Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg 57:161-8;discussion 168-9
Birkmeyer, J D; Welch, H G (1993) Rationing surgery: rules or constraints? Surgery 113:491-7
Sumner 2nd, W (1993) A review of Iliad and Quick Medical Reference for primary care providers. Two diagnostic computer programs. Arch Fam Med 2:87-95
Birkmeyer, J D; Goodnough, L T; AuBuchon, J P et al. (1993) The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 33:544-51
Hogenhuis, W; Stevens, S K; Wang, P et al. (1993) Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome. Circulation 88:II437-46
Sumner 2nd, W; Shultz, E K (1992) Expert systems and expert behavior. J Med Syst 16:183-93
Georgeson, S; Coombs, A T; Eckman, M H (1992) Prophylactic use of the intra-aortic balloon pump in high-risk cardiac patients undergoing noncardiac surgery: a decision analytic view. Am J Med 92:665-78
Tsevat, J; Snydman, D R; Pauker, S G et al. (1991) Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis. Transplantation 52:259-65

Showing the most recent 10 out of 14 publications